Liverpool Clinical Trials Centre, University of Liverpool, a member of Liverpool Health Partners, Institute of Child Health, Alder Hey Children's NHS Foundation Trust, Liverpool, L12 2AP, UK.
School of Medical Sciences, Division of Dentistry, The University of Manchester, Manchester, UK.
Trials. 2021 Jan 4;22(1):5. doi: 10.1186/s13063-020-04886-y.
Cleft palate is among the most common birth abnormalities. The success of primary surgery in the early months of life is crucial for successful feeding, hearing, dental development, and facial growth. Over recent decades, age at palatal surgery in infancy has reduced. The Timing Of Primary Surgery for cleft palate (TOPS) trial aims to determine whether, in infants with cleft palate, it is better to perform primary surgery at age 6 or 12 months (corrected for gestational age).
METHODS/DESIGN: The TOPS trial is an international, two-arm, parallel group, randomised controlled trial. The primary outcome is insufficient velopharyngeal function at 5 years of age. Secondary outcomes, measured at 12 months, 3 years, and 5 years of age, include measures of speech development, safety of the procedure, hearing level, middle ear function, dentofacial development, and growth. The analysis approaches for primary and secondary outcomes are described here, as are the descriptive statistics which will be reported. The TOPS protocol has been published previously.
This paper provides details of the planned statistical analyses for the TOPS trial and will reduce the risk of outcome reporting bias and data-driven results.
ClinicalTrials.gov NCT00993551 . Registered on 9 October 2009.
腭裂是最常见的出生缺陷之一。在生命的早期进行初次手术的成功对于成功喂养、听力、牙齿发育和面部生长至关重要。近几十年来,婴儿腭裂初次手术的年龄有所提前。腭裂初次手术时机(TOPS)试验旨在确定对于腭裂婴儿,在 6 个月还是 12 个月(根据胎龄校正)进行初次手术更好。
方法/设计:TOPS 试验是一项国际性的、双臂、平行组、随机对照试验。主要结局是 5 岁时存在不完全面咽功能。次要结局,在 12 个月、3 年和 5 年时进行测量,包括语音发育、手术安全性、听力水平、中耳功能、牙颌面发育和生长的指标。这里描述了主要和次要结局的分析方法,以及将要报告的描述性统计数据。TOPS 方案先前已发表。
本文提供了 TOPS 试验计划统计分析的详细信息,将降低结局报告偏倚和数据驱动结果的风险。
ClinicalTrials.gov NCT00993551。于 2009 年 10 月 9 日注册。